Welcome to LabBook, our weekly roundup of University of Chicago Medicine & Biological Sciences research news from around campus and the world wide web. Each Friday, LabBook will recap the week on the blog, link to news stories about our faculty and studies, and briefly summarize a handful of recent publications by our researchers.
THIS WEEK ON THE BLOG
Hope you had a fantastic new year. This week we got back in the groove with a couple of stories: First we wrote about an unorthodox fecal “transplant” procedure that can help patients with persistent bowel problems. Sure, there’s an ick factor involved, but how can you not love a story where a mom helps her adorable kid feel better?
And we’ve all used Skype or FaceTime to video chat with friends and family at home. When our new Center for Care and Discovery opens next month, surgeons in the hybrid ORs will be able to do the same thing, using advanced video conferencing equipment installed in the OR and surgical equipment to seamlessly transmit live video from procedures to colleagues, medical students and patient families anywhere in the world.
RESEARCH IN THE NEWS
Elwood Jensen, PhD, was a pioneer in cancer biology research, known worldwide for his pioneering work on how steroid hormones exert their influence through specific receptors in target cells. He joined the University of Chicago as an assistant professor of surgery in 1947, beginning at 55-year career here that included being one of the original members of the Ben May Department for Cancer Research, membership in the National Academy of Sciences in 1974 and the Lasker Award in 2004 for outstanding contributions to basic and clinical medical research. He died on Dec. 16 at the age of 92. His life and work were covered by the New York Times, the Chicago Tribune and the Washington Post, among others.
Jack Gilbert and Daniel Smith from Argonne National Laboratory were in the news again with their Hospital Microbiome project, this time making the front page of the Chicago Tribune.
And finally, research by Andrea King showed that women who take a drug called naltrexone to help stop smoking also gained much less weight after quitting than women who quit by other means. King’s research was covered by US News and World Report.